Career history of Paul W. Sandman
Former positions of Paul W. Sandman
| Companies | Position | Start | End |
|---|---|---|---|
| PDL BIOPHARMA, INC. | Director/Board Member | 07/10/2008 | 14/01/2020 |
| Independent Dir/Board Member | - | 14/01/2020 | |
| BOSTON SCIENTIFIC CORPORATION | General Counsel | 30/04/1993 | 28/02/2008 |
| Corporate Secretary | 30/04/1993 | 28/02/2008 | |
Wang Laboratories, Inc.
 Wang Laboratories, Inc. Information Technology ServicesTechnology Services Wang Laboratories, Inc. develops, markets, and supports software and provides integration and support services for computers. The company is based in Billerica, MA. Wang Laboratories was acquired by Getronics BV, part of Bottega InvestCo SARL from July 07, 2017 on June 08, 1999 for $1,376.08 million. | General Counsel | 31/12/1980 | 31/03/1993 |
| Corporate Secretary | 31/12/1980 | 31/03/1993 |
Training of Paul W. Sandman
| Boston College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Statistics
International
| United States | 6 |
Operational
| General Counsel | 2 |
| Corporate Secretary | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Wang Laboratories, Inc.
Wang Laboratories, Inc. Information Technology ServicesTechnology Services Wang Laboratories, Inc. develops, markets, and supports software and provides integration and support services for computers. The company is based in Billerica, MA. Wang Laboratories was acquired by Getronics BV, part of Bottega InvestCo SARL from July 07, 2017 on June 08, 1999 for $1,376.08 million. | Technology Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Stock Market
- Insiders
- Paul W. Sandman
- Experience
